Search

everythinglearnresearchcommunity

for

Search:↓

Natural extracts may promote hair growth with fewer side effects than conventional treatments.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

A new tool can analyze hair to detect changes due to hormones, genetics, and aging.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Forehead reduction and orbital contouring are important for satisfactory facial feminization in transgender females, with high satisfaction and low long-term problems.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Transgender women can still get testicular cancer, so proper screening is important.

Hair transplantation can help transgender patients affirm their gender identity.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Testosterone increases hair growth and acne in transgender men.

Ensure respectful and inclusive care for transgender and gender-diverse patients during surgery.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Transgender individuals face more barriers and less autonomy in surgical body modifications compared to cisgender individuals.

Psoriasis rates in transgender people are similar to the general population, but hormone therapy might affect it.

Transgender women on estrogen therapy can develop melasma and need proper skin care.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Spironolactone and finasteride are equally effective for hirsutism in transgender women.

Oral minoxidil can effectively treat hair loss in transgender and gender-diverse individuals.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Facial aesthetic procedures improve quality of life for transgender individuals.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Sublingual minoxidil significantly improves hair growth in transgender individuals on testosterone therapy.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.